Sai Parenteral's Limited (NSE:SAIPARENT)

Market Cap	21.32B
Revenue (ttm)	1.63B +6.1%
Net Income	144.54M
EPS	5.43
Shares Out	44.18M
PE Ratio	89.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	159,329
Average Volume	376,900
Open	481.60
Previous Close	485.20
Day's Range	480.95 - 492.00
52-Week Range	392.00 - 526.30
Beta	n/a
RSI	86.67
Earnings Date	May 30, 2026

About Sai Parenteral's

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 296
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAIPARENT

Financial Performance

In fiscal year 2025, Sai Parenteral's's revenue was 1.63 billion, an increase of 6.08% compared to the previous year's 1.54 billion. Earnings were 144.54 million, an increase of 71.76%.